Agenus Inc. (AGEN) Fundamentals

Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.
SHARE INFORMATION
Market CapUS$ 681.690.378
Shares Outstanding282.859.078
Float267.486.024
Percent Float94,57%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 295.664.000
Latest Fiscal EPSUS$ -0,21
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions381
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months13.269.012
Institutional Holdings Percent89,4%
Institutional Sold Previous 3 Months20.241.792
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2,9
Insider Sold Previous 3 Months-
Insider Shares Owned7.902.537
TRADING INFO
52 Week HighUS$ 6,79
52 Week LowUS$ 1,25
52 Week High ChangeUS$ -56,34
21 Day Moving AverageUS$ 1,7195
21 Day Extended Moving AverageUS$ 1,8151
50 Day Moving AverageUS$ 1,7082
50 Day Extended Moving AverageUS$ 1,8507
200 Day Moving AverageUS$ 3,0185
200 Day Extended Moving AverageUS$ 2,7639
10 Day Average Volume7.662.123
20 Day Average Volume6.383.133
30 Day Average Volume5.389.214
50 Day Average Volume5.117.373
Alpha0.001659
Beta1.0791
Standard Deviation0.222875
R20.056018
7 Day Price ChangeUS$ 0,57
7 Day Percent Change30,98%
21 Day Price ChangeUS$ 1,11
21 Day Percent Change85,38%
30 Day Price ChangeUS$ 0,73
30 Day Percent Change43,45%
Month to Date Price ChangeUS$ 0,47
Month to Date Percent Change24,23%
Quarter to Date Price ChangeUS$ 0,47
Quarter to Date Percent Change24,23%
180 Day Price ChangeUS$ -0,59
180 Day Percent Change-19,67%
200 Day Price ChangeUS$ -1,15
200 Day Percent Change-32,3%
Year to Date Price ChangeUS$ -0,81
Year to Date Percent Change-25,16%

Agenus Inc. (AGEN) Key Ratios

PROFITABILITY
EBIT Margin12,9%
EBITDA Margin15,1%
Pre-Tax Profit Margin-267,5%
Profit Margin Count17,3%
Gross Margin26,9%
Profit Margin TOT17,3%
INCOME STATEMENTS
RevenueUS$ 299.157.000
Revenue Per ShareUS$ 1,0576
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book-33,30
Total Debt To Equity4,10
Int Coverage0,60
Current Ratio1,80
Leverage Ratio18,20
Quick Ratio1,60
Long Term Debt To Capital0,75
VALUATION MEASURES
PE Ratio-15,10
Enterprise ValueUS$ 356.029.792
Price to Sales2,2787
Price to Free Cash32,30
PE High Last 5 Years-3,10
Price To Book35,30
Price To Cash Flow958,00
PE Low Last 5 Years-2,40
Price to Tangible Book-33,30
MANAGEMENT EFFECTIVENESS
Receivables Turnover250,90
Invoice Turnover0,00
Assets Turnover0,90
Return Assets-5,67
Return on Equity23,00
Return on Capital-90,21

Agenus Inc. (AGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOGaro H. Armen
Emplyoees441
Last AuditUQ
CIK0001098972
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address3 Forbes Road
Lexington, MA 02421-7305
Websitehttps://www.agenusbio.com
Facsimile+1 781 674-4200
Telephone+1 781 674-4400
Emailinvestor@agenusbio.com
Kürzlich von Ihnen besucht
NASDAQ
AGEN
Agenus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V:de D:20220706 01:49:15